Cargando…

Pre-clinical Evaluation of an Adult Extracoproreal Carbon Dioxide Removal System for Pediatric Application

INTRODUCTION: Adult extracorporeal carbon dioxide removal (ECCO2R) systems and pediatric ECMO share the common objectives of having a low blood flow rate and low priming volume while safely maintaining sufficient respiratory support. The Hemolung is a highly simplified adult ECCO2R system intended f...

Descripción completa

Detalles Bibliográficos
Autores principales: Mussin, Yerbol, Jeffries, Richard, Bulanin, Denis, Zhumadilov, Zhaksybay, Olzhayev, Farkhad, Federspiel, William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: University Library System, University of Pittsburgh 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5960935/
https://www.ncbi.nlm.nih.gov/pubmed/29805896
http://dx.doi.org/10.5195/cajgh.2014.167
_version_ 1783324668549136384
author Mussin, Yerbol
Jeffries, Richard
Bulanin, Denis
Zhumadilov, Zhaksybay
Olzhayev, Farkhad
Federspiel, William
author_facet Mussin, Yerbol
Jeffries, Richard
Bulanin, Denis
Zhumadilov, Zhaksybay
Olzhayev, Farkhad
Federspiel, William
author_sort Mussin, Yerbol
collection PubMed
description INTRODUCTION: Adult extracorporeal carbon dioxide removal (ECCO2R) systems and pediatric ECMO share the common objectives of having a low blood flow rate and low priming volume while safely maintaining sufficient respiratory support. The Hemolung is a highly simplified adult ECCO2R system intended for partial respiratory support in adult patients with acute hypercapnic respiratory failure. The objective of this work was to conduct pre-clinical feasibility studies to determine if a highly efficient, active-mixing, adult ECCO2R system can safely be translated to the pediatric population. METHODS: 14 healthy nonsedated juvenile sheep were used for acute (2 animals) and 7-day chronic (12 animals) in-vivo studies to evaluate treatment safety independently of respiratory related injuries. In all evaluations, we hypothesized that gas exchange capabilities of the Hemolung RAS in this model would be equivalent to the adult configuration performance at similar blood flows - minimum CO2 removal of 50 mL/min at a venous partial pressure of CO2 equal to 45 mmHg. Target blood flow rates were set to a minimum of 280 mL/min. Swan Ganz catheters were used under general anesthesia in the two acute subjects to evaluate blood gas status in the pulmonary artery. RESULTS: The Hemolung RAS was found to have adequate gas exchange and pumping capabilities for full respiratory support for subjects weighing 3 – 25 kg. The Hemolung device was estimated to provide a partial respiratory support for subjects weighing 27 – 34 kg. The seven-day studies in juvenile sheep demonstrated that veno-venous extracorporeal support could be provided safely at low flows with no significant adverse reactions related to device operation. CONCLUSION: The study outcomes suggest the potential use of the Hemolung RAS in a veno-venous pediatric configuration to safely provide respiratory support utilizing a significantly less complex system than traditional pediatric ECMO.
format Online
Article
Text
id pubmed-5960935
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher University Library System, University of Pittsburgh
record_format MEDLINE/PubMed
spelling pubmed-59609352018-05-25 Pre-clinical Evaluation of an Adult Extracoproreal Carbon Dioxide Removal System for Pediatric Application Mussin, Yerbol Jeffries, Richard Bulanin, Denis Zhumadilov, Zhaksybay Olzhayev, Farkhad Federspiel, William Cent Asian J Glob Health Articles INTRODUCTION: Adult extracorporeal carbon dioxide removal (ECCO2R) systems and pediatric ECMO share the common objectives of having a low blood flow rate and low priming volume while safely maintaining sufficient respiratory support. The Hemolung is a highly simplified adult ECCO2R system intended for partial respiratory support in adult patients with acute hypercapnic respiratory failure. The objective of this work was to conduct pre-clinical feasibility studies to determine if a highly efficient, active-mixing, adult ECCO2R system can safely be translated to the pediatric population. METHODS: 14 healthy nonsedated juvenile sheep were used for acute (2 animals) and 7-day chronic (12 animals) in-vivo studies to evaluate treatment safety independently of respiratory related injuries. In all evaluations, we hypothesized that gas exchange capabilities of the Hemolung RAS in this model would be equivalent to the adult configuration performance at similar blood flows - minimum CO2 removal of 50 mL/min at a venous partial pressure of CO2 equal to 45 mmHg. Target blood flow rates were set to a minimum of 280 mL/min. Swan Ganz catheters were used under general anesthesia in the two acute subjects to evaluate blood gas status in the pulmonary artery. RESULTS: The Hemolung RAS was found to have adequate gas exchange and pumping capabilities for full respiratory support for subjects weighing 3 – 25 kg. The Hemolung device was estimated to provide a partial respiratory support for subjects weighing 27 – 34 kg. The seven-day studies in juvenile sheep demonstrated that veno-venous extracorporeal support could be provided safely at low flows with no significant adverse reactions related to device operation. CONCLUSION: The study outcomes suggest the potential use of the Hemolung RAS in a veno-venous pediatric configuration to safely provide respiratory support utilizing a significantly less complex system than traditional pediatric ECMO. University Library System, University of Pittsburgh 2014-12-12 /pmc/articles/PMC5960935/ /pubmed/29805896 http://dx.doi.org/10.5195/cajgh.2014.167 Text en New articles in this journal are licensed under a Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Articles
Mussin, Yerbol
Jeffries, Richard
Bulanin, Denis
Zhumadilov, Zhaksybay
Olzhayev, Farkhad
Federspiel, William
Pre-clinical Evaluation of an Adult Extracoproreal Carbon Dioxide Removal System for Pediatric Application
title Pre-clinical Evaluation of an Adult Extracoproreal Carbon Dioxide Removal System for Pediatric Application
title_full Pre-clinical Evaluation of an Adult Extracoproreal Carbon Dioxide Removal System for Pediatric Application
title_fullStr Pre-clinical Evaluation of an Adult Extracoproreal Carbon Dioxide Removal System for Pediatric Application
title_full_unstemmed Pre-clinical Evaluation of an Adult Extracoproreal Carbon Dioxide Removal System for Pediatric Application
title_short Pre-clinical Evaluation of an Adult Extracoproreal Carbon Dioxide Removal System for Pediatric Application
title_sort pre-clinical evaluation of an adult extracoproreal carbon dioxide removal system for pediatric application
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5960935/
https://www.ncbi.nlm.nih.gov/pubmed/29805896
http://dx.doi.org/10.5195/cajgh.2014.167
work_keys_str_mv AT mussinyerbol preclinicalevaluationofanadultextracoprorealcarbondioxideremovalsystemforpediatricapplication
AT jeffriesrichard preclinicalevaluationofanadultextracoprorealcarbondioxideremovalsystemforpediatricapplication
AT bulanindenis preclinicalevaluationofanadultextracoprorealcarbondioxideremovalsystemforpediatricapplication
AT zhumadilovzhaksybay preclinicalevaluationofanadultextracoprorealcarbondioxideremovalsystemforpediatricapplication
AT olzhayevfarkhad preclinicalevaluationofanadultextracoprorealcarbondioxideremovalsystemforpediatricapplication
AT federspielwilliam preclinicalevaluationofanadultextracoprorealcarbondioxideremovalsystemforpediatricapplication